Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
66.9 EUR | +0.38% | +1.90% | +96.76% |
05-06 | MORPHOSYS : UBS reiterates its Neutral rating | ZD |
04-30 | European Equities Traded in the US as American Depositary Receipts Decline | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+96.76% | 2.7B | |
+22.81% | 47.9B | |
+46.56% | 41.42B | |
-1.88% | 40.7B | |
-6.20% | 28.92B | |
+11.33% | 25.55B | |
-21.00% | 19.27B | |
-1.43% | 12.15B | |
+30.73% | 12.14B | |
-0.48% | 11.99B |
- Stock Market
- Equities
- MOR Stock
- News MorphoSys AG
- MorphoSys : Swissmedic Accepts MorphoSys-Incyte Application for B-Cell Lymphoma Treatment